+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Clinical Laboratory Tests Market Research Report by Type, End-user, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 131 Pages
  • October 2022
  • Region: United States
  • 360iResearch™
  • ID: 5313781
UP TO OFF until Dec 31st 2022
The United States Clinical Laboratory Tests Market size was estimated at USD 6,312.52 million in 2021, USD 7,181.83 million in 2022, and is projected to grow at a CAGR of 10.21% to reach USD 11,317.66 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Clinical Laboratory Tests to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Basic metabolic panel tests, BUN creatinine tests, Complete Blood Count, Comprehensive metabolic panel tests, Electrolytes testing, HbA1c tests, HGB/HCT tests, Lipid panel tests, Liver panel tests, and Renal panel tests. The Liver panel tests is further studied across Autoimmune disorders, Bile duct obstruction, Bone disease, Hepatitis, Liver Cancer, and Liver Cirrhosis.
  • Based on End-user, the market was studied across Central Laboratories and Primary Clinics.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies This research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Clinical Laboratory Tests market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Laboratory Tests Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Clinical Laboratory Tests Market, including Abbott Laboratories, Associated Regional and University Pathologists, Inc., Bioscientia Institut für Medizinische Diagnostik GmbH, Biosino Bio-technology and Science Inc., Charles River Laboratories, Inc, Cinven, Clinical Reference Laboratory, Inc., DaVita Inc, Eurofins Scientific, Fresenius Medical Care Holdings, Inc., Fullerton Healthcare Corporation Limited, Healthscope, KingMed Diagnostics, Laboratory Corporation of America Holdings (LabCorp), LifeLabs, Mayo Foundation for Medical Education and Research, Merck KgaA, Neogenomics Laboratories, Inc, Novartis International AG, OPKO Health, Inc., PerkinElmer, Inc., Qiagen .N.V., Quest Diagnostics, Inc., Siemens Healthineers AG, Sonic Healthcare Limited, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Clinical Laboratory Tests Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Clinical Laboratory Tests Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Clinical Laboratory Tests Market?
4. What is the competitive strategic window for opportunities in the United States Clinical Laboratory Tests Market?
5. What are the technology trends and regulatory frameworks in the United States Clinical Laboratory Tests Market?
6. What is the market share of the leading vendors in the United States Clinical Laboratory Tests Market?
7. What modes and strategic moves are considered suitable for entering the United States Clinical Laboratory Tests Market?
Frequently Asked Questions about the U.S. Clinical Laboratory Tests Market

What is the estimated value of the U.S. Clinical Laboratory Tests Market?

The U.S. Clinical Laboratory Tests Market was estimated to be valued at $6312.52 Million in 2021.

What is the growth rate of the U.S. Clinical Laboratory Tests Market?

The growth rate of the U.S. Clinical Laboratory Tests Market is 10.2%, with an estimated value of $11317.66 Million by 2027.

What is the forecasted size of the U.S. Clinical Laboratory Tests Market?

The U.S. Clinical Laboratory Tests Market is estimated to be worth $11317.66 Million by 2027.

Who are the key companies in the U.S. Clinical Laboratory Tests Market?

Key companies in the U.S. Clinical Laboratory Tests Market include Abbott Laboratories, Associated Regional and University Pathologists, Inc., Bioscientia Institut für Medizinische Diagnostik GmbH, Biosino Bio, technology and Science Inc., Charles River Laboratories, Inc, Cinven, Clinical Reference Laboratory, Inc. and Eurofins Scientific.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Clinical Laboratory Tests Market, by Type
6.1. Introduction
6.2. Basic metabolic panel tests
6.3. BUN creatinine tests
6.4. Complete Blood Count
6.5. Comprehensive metabolic panel tests
6.6. Electrolytes testing
6.7. HbA1c tests
6.8. HGB/HCT tests
6.9. Lipid panel tests
6.10. Liver panel tests
6.11.1. Autoimmune disorders
6.11.2. Bile duct obstruction
6.11.3. Bone disease
6.11.4. Hepatitis
6.11.5. Liver Cancer
6.11.6. Liver Cirrhosis
6.11. Renal panel tests
7. Clinical Laboratory Tests Market, by End-user
7.1. Introduction
7.2. Central Laboratories
7.3. Primary Clinics
8. California Clinical Laboratory Tests Market
8.1. Introduction
9. Florida Clinical Laboratory Tests Market
9.1. Introduction
10. Illinois Clinical Laboratory Tests Market
10.1. Introduction
11. New York Clinical Laboratory Tests Market
11.1. Introduction
12. Ohio Clinical Laboratory Tests Market
12.1. Introduction
13. Pennsylvania Clinical Laboratory Tests Market
13.1. Introduction
14. Texas Clinical Laboratory Tests Market
14.1. Introduction
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis, By Key Player
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. Abbott Laboratories
16.1.1. Business Overview
16.1.2. Key Executives
16.1.3. Product & Services
16.2. Associated Regional and University Pathologists, Inc.
16.2.1. Business Overview
16.2.2. Key Executives
16.2.3. Product & Services
16.3. Bioscientia Institut für Medizinische Diagnostik GmbH
16.3.1. Business Overview
16.3.2. Key Executives
16.3.3. Product & Services
16.4. Biosino Bio-technology and Science Inc.
16.4.1. Business Overview
16.4.2. Key Executives
16.4.3. Product & Services
16.5. Charles River Laboratories, Inc
16.5.1. Business Overview
16.5.2. Key Executives
16.5.3. Product & Services
16.6. Cinven
16.6.1. Business Overview
16.6.2. Key Executives
16.6.3. Product & Services
16.7. Clinical Reference Laboratory, Inc.
16.7.1. Business Overview
16.7.2. Key Executives
16.7.3. Product & Services
16.8. DaVita Inc
16.8.1. Business Overview
16.8.2. Key Executives
16.8.3. Product & Services
16.9. Eurofins Scientific
16.9.1. Business Overview
16.9.2. Key Executives
16.9.3. Product & Services
16.10. Fresenius Medical Care Holdings, Inc.
16.10.1. Business Overview
16.10.2. Key Executives
16.10.3. Product & Services
16.11. Fullerton Healthcare Corporation Limited
16.11.1. Business Overview
16.11.2. Key Executives
16.11.3. Product & Services
16.12. Healthscope
16.12.1. Business Overview
16.12.2. Key Executives
16.12.3. Product & Services
16.13. KingMed Diagnostics
16.13.1. Business Overview
16.13.2. Key Executives
16.13.3. Product & Services
16.14. Laboratory Corporation of America Holdings (LabCorp)
16.14.1. Business Overview
16.14.2. Key Executives
16.14.3. Product & Services
16.15. LifeLabs
16.15.1. Business Overview
16.15.2. Key Executives
16.15.3. Product & Services
16.16. Mayo Foundation for Medical Education and Research
16.16.1. Business Overview
16.16.2. Key Executives
16.16.3. Product & Services
16.17. Merck KgaA
16.17.1. Business Overview
16.17.2. Key Executives
16.17.3. Product & Services
16.18. Neogenomics Laboratories, Inc
16.18.1. Business Overview
16.18.2. Key Executives
16.18.3. Product & Services
16.19. Novartis International AG
16.19.1. Business Overview
16.19.2. Key Executives
16.19.3. Product & Services
16.20. OPKO Health, Inc.
16.20.1. Business Overview
16.20.2. Key Executives
16.20.3. Product & Services
16.21. PerkinElmer, Inc.
16.21.1. Business Overview
16.21.2. Key Executives
16.21.3. Product & Services
16.22. Qiagen .N.V.
16.22.1. Business Overview
16.22.2. Key Executives
16.22.3. Product & Services
16.23. Quest Diagnostics, Inc.
16.23.1. Business Overview
16.23.2. Key Executives
16.23.3. Product & Services
16.24. Siemens Healthineers AG
16.24.1. Business Overview
16.24.2. Key Executives
16.24.3. Product & Services
16.25. Sonic Healthcare Limited
16.25.1. Business Overview
16.25.2. Key Executives
16.25.3. Product & Services
16.26. Thermo Fisher Scientific Inc.
16.26.1. Business Overview
16.26.2. Key Executives
16.26.3. Product & Services
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES CLINICAL LABORATORY TESTS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, 2021 VS 2027
FIGURE 3. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. UNITED STATES CLINICAL LABORATORY TESTS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 7. UNITED STATES CLINICAL LABORATORY TESTS MARKET DYNAMICS
FIGURE 8. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES CLINICAL LABORATORY TESTS MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2027
FIGURE 11. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL TESTS, 2018-2027 (USD MILLION)
FIGURE 12. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY BUN CREATININE TESTS, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPLETE BLOOD COUNT, 2018-2027 (USD MILLION)
FIGURE 14. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL TESTS, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY ELECTROLYTES TESTING, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY HBA1C TESTS, 2018-2027 (USD MILLION)
FIGURE 17. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY HGB/HCT TESTS, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY LIPID PANEL TESTS, 2018-2027 (USD MILLION)
FIGURE 19. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER PANEL TESTS, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2027 (USD MILLION)
FIGURE 21. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY BILE DUCT OBSTRUCTION, 2018-2027 (USD MILLION)
FIGURE 22. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY BONE DISEASE, 2018-2027 (USD MILLION)
FIGURE 23. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY HEPATITIS, 2018-2027 (USD MILLION)
FIGURE 24. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER CANCER, 2018-2027 (USD MILLION)
FIGURE 25. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER CIRRHOSIS, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY RENAL PANEL TESTS, 2018-2027 (USD MILLION)
FIGURE 27. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 28. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES CLINICAL LABORATORY TESTS MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2027
FIGURE 30. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY CENTRAL LABORATORIES, 2018-2027 (USD MILLION)
FIGURE 31. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY PRIMARY CLINICS, 2018-2027 (USD MILLION)
FIGURE 32. CALIFORNIA CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. FLORIDA CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. ILLINOIS CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. NEW YORK CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. OHIO CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. PENNSYLVANIA CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. TEXAS CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. UNITED STATES CLINICAL LABORATORY TESTS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 40. UNITED STATES CLINICAL LABORATORY TESTS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 41. UNITED STATES CLINICAL LABORATORY TESTS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. UNITED STATES CLINICAL LABORATORY TESTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL TESTS, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL TESTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY BUN CREATININE TESTS, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY BUN CREATININE TESTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPLETE BLOOD COUNT, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL TESTS, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL TESTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY ELECTROLYTES TESTING, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY ELECTROLYTES TESTING, BY STATE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY HBA1C TESTS, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY HBA1C TESTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY HGB/HCT TESTS, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY HGB/HCT TESTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY LIPID PANEL TESTS, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY LIPID PANEL TESTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 22. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER PANEL TESTS, 2018-2027 (USD MILLION)
TABLE 23. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER PANEL TESTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 24. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2027 (USD MILLION)
TABLE 25. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 26. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY BILE DUCT OBSTRUCTION, 2018-2027 (USD MILLION)
TABLE 27. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY BILE DUCT OBSTRUCTION, BY STATE, 2018-2027 (USD MILLION)
TABLE 28. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY BONE DISEASE, 2018-2027 (USD MILLION)
TABLE 29. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY BONE DISEASE, BY STATE, 2018-2027 (USD MILLION)
TABLE 30. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY HEPATITIS, 2018-2027 (USD MILLION)
TABLE 31. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY HEPATITIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 32. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER CANCER, 2018-2027 (USD MILLION)
TABLE 33. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER CANCER, BY STATE, 2018-2027 (USD MILLION)
TABLE 34. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER CIRRHOSIS, 2018-2027 (USD MILLION)
TABLE 35. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER CIRRHOSIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 36. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY RENAL PANEL TESTS, 2018-2027 (USD MILLION)
TABLE 37. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY RENAL PANEL TESTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 38. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 39. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY CENTRAL LABORATORIES, 2018-2027 (USD MILLION)
TABLE 40. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY CENTRAL LABORATORIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 41. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY PRIMARY CLINICS, 2018-2027 (USD MILLION)
TABLE 42. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY PRIMARY CLINICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 43. CALIFORNIA CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 44. CALIFORNIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 45. CALIFORNIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 46. FLORIDA CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 47. FLORIDA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 48. FLORIDA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 49. ILLINOIS CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 50. ILLINOIS CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 51. ILLINOIS CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 52. NEW YORK CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 53. NEW YORK CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 54. NEW YORK CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 55. OHIO CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 56. OHIO CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 57. OHIO CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 58. PENNSYLVANIA CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 59. PENNSYLVANIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 60. PENNSYLVANIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 61. TEXAS CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 62. TEXAS CLINICAL LABORATORY TESTS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 63. TEXAS CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 64. UNITED STATES CLINICAL LABORATORY TESTS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 65. UNITED STATES CLINICAL LABORATORY TESTS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 66. UNITED STATES CLINICAL LABORATORY TESTS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 67. UNITED STATES CLINICAL LABORATORY TESTS MARKET RANKING, BY KEY PLAYER, 2021
TABLE 68. UNITED STATES CLINICAL LABORATORY TESTS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 69. UNITED STATES CLINICAL LABORATORY TESTS MARKET MERGER & ACQUISITION
TABLE 70. UNITED STATES CLINICAL LABORATORY TESTS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 71. UNITED STATES CLINICAL LABORATORY TESTS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 72. UNITED STATES CLINICAL LABORATORY TESTS MARKET INVESTMENT & FUNDING
TABLE 73. UNITED STATES CLINICAL LABORATORY TESTS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 74. UNITED STATES CLINICAL LABORATORY TESTS MARKET: LICENSE & PRICING

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • Associated Regional and University Pathologists, Inc.
  • Bioscientia Institut für Medizinische Diagnostik GmbH
  • Biosino Bio-technology and Science Inc.
  • Charles River Laboratories, Inc
  • Cinven
  • Clinical Reference Laboratory, Inc.
  • DaVita Inc
  • Eurofins Scientific
  • Fresenius Medical Care Holdings, Inc.
  • Fullerton Healthcare Corporation Limited
  • Healthscope
  • KingMed Diagnostics
  • Laboratory Corporation of America Holdings (LabCorp)
  • LifeLabs
  • Mayo Foundation for Medical Education and Research
  • Merck KgaA
  • Neogenomics Laboratories, Inc
  • Novartis International AG
  • OPKO Health, Inc.
  • PerkinElmer, Inc.
  • Qiagen .N.V.
  • Quest Diagnostics, Inc.
  • Siemens Healthineers AG
  • Sonic Healthcare Limited
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...